跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20,043 条关于
“PCSK9 inhibitor”
全部
20,043
临床试验
9,814
药物
4,095
机构
20
资讯
6,114
2年前
AstraZeneca Unveils Oral Small Molecule PCSK9 Inhibitor AZD0780
去年
LEQVIO Emerges as Leading PCSK9 Inhibitor in Cholesterol Management Across Major Markets
6个月前
Merck Presents Positive Phase 3 Data for Oral PCSK9 Inhibitor Enlicitide at ACC.26
去年
AstraZeneca's Oral PCSK9 Inhibitor Shows Promise in Phase 1 Trial
9个月前
Everest Medicines Secures Exclusive Greater China Rights to Novel PCSK9 Inhibitor Lerodalcibep
9个月前
FDA Approves Lerodalcibep-liga (LEROCHOL) as Third-Generation PCSK9 Inhibitor for Cholesterol Management
10个月前
PCSK9 Inhibitor Alirocumab Safely Reduces Cholesterol by 50% in Heart Transplant Patients
去年
UPC Dismisses Sanofi's Infringement Claim Against Amgen's Repatha in Landmark PCSK9 Inhibitor Ruling
3年前
Merck Launches First Phase 3 Program for Oral PCSK9 Inhibitor MK-0616 to Treat High Cholesterol
去年
Merck's Enlicitide Shows Promise as First Oral PCSK9 Inhibitor in Phase 3 Trials
第 1 页,共 612 页
上一页
下一页